Prkag2tm3.1Mrl
Targeted Allele Detail
|
|
| Symbol: |
Prkag2tm3.1Mrl |
| Name: |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit; targeted mutation 3.1, Merck Research Laboratory |
| MGI ID: |
MGI:6435148 |
| Synonyms: |
AMPKgamma2RG |
| Gene: |
Prkag2 Location: Chr5:25067742-25305640 bp, - strand Genetic Position: Chr5, 11.93 cM
|
| Alliance: |
Prkag2tm3.1Mrl page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:237375
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6NTac
|
|
| Allele Type: |
|
Targeted (Humanized sequence) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: A CGG to GGC change resulting in an arginine to glycine substitution at amino acid 528 (p.R528G) was introduced into the Prkag2 exon 15. The positive selection marker (Puromycin resistance - PuroR) was flanked by F3 sites and inserted in intron 14. The constitutive point mutation allele was generated after Flp-mediated recombination. This corresponds to the human p.R531G mutation associated with Wolff-Parkinson-White syndrome.
(J:237375)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Prkag2 Mutation: |
55 strains or lines available
|
|
| Original: |
J:237375 Yang X, et al., Physiological Expression of AMPKgamma2RG Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice. J Biol Chem. 2016 Nov 04;291(45):23428-23439 |
| All: |
2 reference(s) |
|